SCHEMBL9998221

SCHEMBL9998221

CC(=O)OCC(=Cc1cccc(Cl)c1)C(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FBP1 P09467 1/20 0.44
AKR1C3 P42330 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 1/20 0.42
PTGS2 P35354 1/20 0.41
HPGD P15428 2/20 0.41
USP2 O75604 1/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
PKM P14618 1/20 0.39
KCNA3 P22001 1/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 1/20 0.38
CYP2C19 P33261 1/20 0.38
CACNA1B Q00975 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9997664 0.84 LMNA (0.44) FBP1PTGS2KMT2AMEN1ALDH1A1
SCHEMBL9997815 0.84 CACNA1B (0.50) FBP1AKR1C3CYP1A2CYP2C9PTGS2
SCHEMBL9997812 0.84 CACNA1B (0.50) FBP1AKR1C3CYP1A2CYP2C9PTGS2
SCHEMBL9998284 0.83 MAPT (0.48) FBP1AKR1C3PTGS2KMT2AMEN1
SCHEMBL9997762 0.83 PPARG (0.37) HPGDKMT2AMEN1ALDH1A1KDM4E
SCHEMBL9998455 0.83 PKM (0.45) AKR1C3KMT2AMEN1ALDH1A1KDM4E
SCHEMBL9998226 0.82 CYP2C9 (0.43) FBP1AKR1C3CYP2C9PTGS2HPGD
SCHEMBL9998219 0.82 HDAC4 (0.39) PTGS2KMT2AMEN1ALDH1A1KDM4E
SCHEMBL9998202 0.82 MEN1 (0.47) FBP1AKR1C3HPGDKMT2AMEN1
SCHEMBL9997678 0.81 ACHE (0.38) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 FBP1 181/4885AKR1C3 291/4885CYP1A2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.